Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
alnylam pharmaceuticals
fda
new york blog main
new york top stories
san diego blog main
san diego top stories
biotech
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
boston
celgene
clinical trials
drug prices
hereditary transthyretin amyloidosis
medical
patisiran
pfizer
rna interference
What
drug
9
×
gene
9
×
therapy
bio
disease
fda
roundup
approval
approves
medicine
new
prices
protein
researchers
treat
way
accelerating
administration
advanced
advances
ago
allowing
alnylam
alnylam’s
alzheimer’s
amounts
analyze
appeared
aren’t
artificial
bacteria
bff
bgr
called
caught
causing
celebrated
cells
changed
chemistry
Language
unset
Current search:
gene
×
drug
×
@bgr.com
1 year ago
Revolutionary new gene therapy gel can heal wounds that are decades old
@thenextweb.com
1 year ago
A celebrated AI has learned a new trick: How to do chemistry
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@slashgear.com
4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@engadget.com
4 years ago
Gene-modified viruses rescue patient from drug-resistant 'superbug'
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More